The University of Chicago Header Logo

Connection

Fredric L. Coe to Male

This is a "connection" page, showing publications Fredric L. Coe has written about Male.
Connection Strength

1.082
  1. Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870.
    View in: PubMed
    Score: 0.039
  2. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
    View in: PubMed
    Score: 0.037
  3. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
    View in: PubMed
    Score: 0.035
  4. A laboratory-based algorithm to predict future kidney function decline in older adults with reduced estimated glomerular filtration rate?. Clin Nephrol. 2019 Sep; 92(3):113-122.
    View in: PubMed
    Score: 0.035
  5. Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629.
    View in: PubMed
    Score: 0.031
  6. Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access. PLoS One. 2016; 11(4):e0152873.
    View in: PubMed
    Score: 0.027
  7. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
    View in: PubMed
    Score: 0.025
  8. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
    View in: PubMed
    Score: 0.024
  9. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60.
    View in: PubMed
    Score: 0.023
  10. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9.
    View in: PubMed
    Score: 0.022
  11. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53.
    View in: PubMed
    Score: 0.021
  12. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
    View in: PubMed
    Score: 0.019
  13. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
    View in: PubMed
    Score: 0.019
  14. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
    View in: PubMed
    Score: 0.018
  15. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2190-4.
    View in: PubMed
    Score: 0.017
  16. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
    View in: PubMed
    Score: 0.016
  17. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9.
    View in: PubMed
    Score: 0.014
  18. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75.
    View in: PubMed
    Score: 0.014
  19. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9.
    View in: PubMed
    Score: 0.014
  20. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7.
    View in: PubMed
    Score: 0.014
  21. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
    View in: PubMed
    Score: 0.014
  22. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6.
    View in: PubMed
    Score: 0.014
  23. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
    View in: PubMed
    Score: 0.013
  24. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
    View in: PubMed
    Score: 0.013
  25. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90.
    View in: PubMed
    Score: 0.013
  26. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43.
    View in: PubMed
    Score: 0.012
  27. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
    View in: PubMed
    Score: 0.012
  28. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
    View in: PubMed
    Score: 0.012
  29. Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9.
    View in: PubMed
    Score: 0.012
  30. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
    View in: PubMed
    Score: 0.011
  31. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
    View in: PubMed
    Score: 0.010
  32. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
    View in: PubMed
    Score: 0.010
  33. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12.
    View in: PubMed
    Score: 0.010
  34. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87.
    View in: PubMed
    Score: 0.010
  35. Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60.
    View in: PubMed
    Score: 0.010
  36. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943.
    View in: PubMed
    Score: 0.010
  37. Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
    View in: PubMed
    Score: 0.009
  38. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta. 1999 Nov; 289(1-2):57-68.
    View in: PubMed
    Score: 0.009
  39. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85.
    View in: PubMed
    Score: 0.009
  40. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16.
    View in: PubMed
    Score: 0.009
  41. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72.
    View in: PubMed
    Score: 0.008
  42. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342.
    View in: PubMed
    Score: 0.008
  43. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34.
    View in: PubMed
    Score: 0.008
  44. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
    View in: PubMed
    Score: 0.008
  45. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
    View in: PubMed
    Score: 0.008
  46. Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81.
    View in: PubMed
    Score: 0.008
  47. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8.
    View in: PubMed
    Score: 0.008
  48. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
    View in: PubMed
    Score: 0.008
  49. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
    View in: PubMed
    Score: 0.008
  50. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33.
    View in: PubMed
    Score: 0.007
  51. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5.
    View in: PubMed
    Score: 0.007
  52. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
    View in: PubMed
    Score: 0.007
  53. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90.
    View in: PubMed
    Score: 0.007
  54. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7.
    View in: PubMed
    Score: 0.007
  55. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13.
    View in: PubMed
    Score: 0.007
  56. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163.
    View in: PubMed
    Score: 0.007
  57. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
    View in: PubMed
    Score: 0.006
  58. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70.
    View in: PubMed
    Score: 0.006
  59. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69.
    View in: PubMed
    Score: 0.006
  60. An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int. 1994 Jun; 45(6):1722-30.
    View in: PubMed
    Score: 0.006
  61. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8.
    View in: PubMed
    Score: 0.006
  62. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65.
    View in: PubMed
    Score: 0.006
  63. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
    View in: PubMed
    Score: 0.006
  64. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res. 1992 Mar 15; 52(6):1573-9.
    View in: PubMed
    Score: 0.005
  65. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
    View in: PubMed
    Score: 0.005
  66. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42.
    View in: PubMed
    Score: 0.005
  67. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol. 1991 Apr; 260(4 Pt 2):F569-78.
    View in: PubMed
    Score: 0.005
  68. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int. 2010 Jan; 14(1):39-46.
    View in: PubMed
    Score: 0.004
  69. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
    View in: PubMed
    Score: 0.004
  70. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23.
    View in: PubMed
    Score: 0.004
  71. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
    View in: PubMed
    Score: 0.004
  72. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
    View in: PubMed
    Score: 0.004
  73. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009 Jan; 181(1):161-6.
    View in: PubMed
    Score: 0.004
  74. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.004
  75. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
    View in: PubMed
    Score: 0.004
  76. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.004
  77. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6.
    View in: PubMed
    Score: 0.004
  78. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
    View in: PubMed
    Score: 0.004
  79. Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim.
    View in: PubMed
    Score: 0.004
  80. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
    View in: PubMed
    Score: 0.004
  81. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53.
    View in: PubMed
    Score: 0.004
  82. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11.
    View in: PubMed
    Score: 0.004
  83. The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40.
    View in: PubMed
    Score: 0.004
  84. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801.
    View in: PubMed
    Score: 0.004
  85. Effects of medium pH on duodenal and ileal calcium active transport in the rat. Am J Physiol. 1986 Nov; 251(5 Pt 1):G695-700.
    View in: PubMed
    Score: 0.004
  86. Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis. Am J Physiol. 1986 Nov; 251(5 Pt 2):F911-8.
    View in: PubMed
    Score: 0.004
  87. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
    View in: PubMed
    Score: 0.003
  88. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol. 1986 Jul; 251(1 Pt 2):F17-24.
    View in: PubMed
    Score: 0.003
  89. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96.
    View in: PubMed
    Score: 0.003
  90. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90.
    View in: PubMed
    Score: 0.003
  91. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35.
    View in: PubMed
    Score: 0.003
  92. Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57.
    View in: PubMed
    Score: 0.003
  93. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7.
    View in: PubMed
    Score: 0.003
  94. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
    View in: PubMed
    Score: 0.003
  95. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest. 1985 Oct; 76(4):1599-604.
    View in: PubMed
    Score: 0.003
  96. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62.
    View in: PubMed
    Score: 0.003
  97. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. J Lab Clin Med. 1985 Sep; 106(3):286-92.
    View in: PubMed
    Score: 0.003
  98. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9.
    View in: PubMed
    Score: 0.003
  99. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
    View in: PubMed
    Score: 0.003
  100. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9.
    View in: PubMed
    Score: 0.003
  101. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol. 1984 Nov; 247(5 Pt 2):F746-52.
    View in: PubMed
    Score: 0.003
  102. Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest. 1984 Sep; 74(3):805-11.
    View in: PubMed
    Score: 0.003
  103. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
    View in: PubMed
    Score: 0.003
  104. Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol. 1984 Feb; 246(2 Pt 2):F140-5.
    View in: PubMed
    Score: 0.003
  105. Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5.
    View in: PubMed
    Score: 0.003
  106. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
    View in: PubMed
    Score: 0.003
  107. Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport. Am J Physiol. 1983 Feb; 244(2):G111-5.
    View in: PubMed
    Score: 0.003
  108. Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. Trans Assoc Am Physicians. 1983; 96:225-33.
    View in: PubMed
    Score: 0.003
  109. Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet. Am J Physiol. 1982 Dec; 243(6):F570-5.
    View in: PubMed
    Score: 0.003
  110. Effects of somatostatin on intestinal calcium transport in the rat. Am J Physiol. 1981 Sep; 241(3):G215-21.
    View in: PubMed
    Score: 0.002
  111. Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
    View in: PubMed
    Score: 0.002
  112. Kinetic characteristics of calcium absorption and secretion by rat colon. Am J Physiol. 1981 May; 240(5):G350-4.
    View in: PubMed
    Score: 0.002
  113. Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45.
    View in: PubMed
    Score: 0.002
  114. Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
    View in: PubMed
    Score: 0.002
  115. Primary hyperparathyroidism and basal cell nevus syndrome. Ann Intern Med. 1980 Jul; 93(1):147.
    View in: PubMed
    Score: 0.002
  116. Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1.
    View in: PubMed
    Score: 0.002
  117. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8.
    View in: PubMed
    Score: 0.002
  118. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7.
    View in: PubMed
    Score: 0.002
  119. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50.
    View in: PubMed
    Score: 0.002
  120. Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40.
    View in: PubMed
    Score: 0.002
  121. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12.
    View in: PubMed
    Score: 0.002
  122. Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
    View in: PubMed
    Score: 0.002
  123. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
    View in: PubMed
    Score: 0.002
  124. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9.
    View in: PubMed
    Score: 0.002
  125. The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23.
    View in: PubMed
    Score: 0.002
  126. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
    View in: PubMed
    Score: 0.002
  127. Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92.
    View in: PubMed
    Score: 0.002
  128. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800.
    View in: PubMed
    Score: 0.002
  129. Compensatory phosphaturia after unilateral nephrectomy in the rat. Am J Physiol. 1976 Nov; 231(5 Pt. 1):1625-9.
    View in: PubMed
    Score: 0.002
  130. Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9.
    View in: PubMed
    Score: 0.002
  131. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73.
    View in: PubMed
    Score: 0.002
  132. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
    View in: PubMed
    Score: 0.002
  133. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5.
    View in: PubMed
    Score: 0.002
  134. The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55.
    View in: PubMed
    Score: 0.001
  135. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
    View in: PubMed
    Score: 0.001
  136. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42.
    View in: PubMed
    Score: 0.001
  137. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61.
    View in: PubMed
    Score: 0.001
  138. Hexose monophosphate shunt activity in compensatory renal hypertrophy. Proc Soc Exp Biol Med. 1968 Dec; 129(3):809-12.
    View in: PubMed
    Score: 0.001
  139. Protein synthesis during compensatory renal hypertrophy. Am J Physiol. 1967 Dec; 213(6):1585-9.
    View in: PubMed
    Score: 0.001
  140. Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. Surgery. 1986 Sep; 100(3):494-9.
    View in: PubMed
    Score: 0.001
  141. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9.
    View in: PubMed
    Score: 0.001
  142. Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat. Am J Physiol. 1982 Jun; 242(6):G575-81.
    View in: PubMed
    Score: 0.001
  143. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91.
    View in: PubMed
    Score: 0.001
  144. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
    View in: PubMed
    Score: 0.001
  145. Effects of chlorothiazide administration and dietary calcium restriction on parathyroid function, vitamin D metabolism and intestinal calcium absorption in the rat. Adv Exp Med Biol. 1982; 151:501-7.
    View in: PubMed
    Score: 0.001
  146. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
    View in: PubMed
    Score: 0.001
  147. Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81.
    View in: PubMed
    Score: 0.001
  148. Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May; 78(5 Pt 1):1069-79.
    View in: PubMed
    Score: 0.001
  149. Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport. Am J Physiol. 1980 Feb; 238(2):G75-8.
    View in: PubMed
    Score: 0.001
  150. Viomycin-induced electrolyte abnormalities. Respiration. 1980; 40(5):284-92.
    View in: PubMed
    Score: 0.001
  151. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4.
    View in: PubMed
    Score: 0.001
  152. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
    View in: PubMed
    Score: 0.000
  153. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14.
    View in: PubMed
    Score: 0.000
  154. Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders. Medicine (Baltimore). 1966 Jan; 45(1):1-50.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.